Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Real-time Estimate Cboe BZX
Other stock markets
 12:55:38 2024-05-29 EDT 		5-day change 1st Jan Change
1.845 USD -1.86% Intraday chart for Coherus BioSciences, Inc. -12.56% -44.59%
05-23 Coherus Biosciences, Inc. Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-Chemokine Receptor 8 Antibody, CHS-114, at the 2024 American Society of Clinical Oncology Annual Meeting CI
05-13 Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
COHERUS BIOSCIENCES, INC. Stock Coherus BioSciences, Inc.
 216M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.71B -
ARGENX SE Stock argenx SE
 21.83B -
GENMAB A/S Stock Genmab A/S
 18.18B
  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. Sector Chart